Back to 
UBS Group AG
UBS Group AG
OCDXShowing 0 of 6 quarters
Position history for UBS Group AG's holdings in ORTHO CLINICAL DIAGNOSTICS H
As of its Q1 2022 13F, Ubs held 426,885 shares of OCDX (Ortho Clinical Diagnostics), worth $8M. Ubs' 13F filings listed OCDX from Q1 2021 to Q1 2022, 5 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of OCDX: Carlyle Group Inc.